Mabwell (Shanghai) Bioscience Co., Ltd. Class H(HK:2493)
HK$17.80-0.20 (-1.11%)
HK:2493
Mabwell (Shanghai) Bioscience Co., Ltd. Class H financials statements
HK$17.80
At close:-0.20 (-1.11%)
Want to see HK:2493 full AI Analyst Report?
Mabwell (Shanghai) Bioscience Co., Ltd. Class H (2493) Financial Statements
1 Followers
Mabwell (Shanghai) Bioscience Co., Ltd. Class H Financial Overview
Mabwell (Shanghai) Bioscience Co., Ltd. Class H's market cap is currently ¥10.95B. The company's EPS TTM is ¥-2.59; its P/E ratio is -5.84; Mabwell (Shanghai) Bioscience Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 662.52M | ¥ 199.78M | ¥ 127.84M | ¥ 27.73M | ¥ 15.96M |
| Gross Profit | ¥ 598.05M | ¥ 170.83M | ¥ 126.47M | ¥ 27.66M | ¥ -72.92M |
| Operating Income | ¥ -955.32M | ¥ -1.04B | ¥ -1.05B | ― | ¥ -785.47M |
| EBITDA | ¥ -647.88M | ¥ -844.97M | ¥ -937.63M | ¥ -858.54M | ¥ -699.62M |
| Net Income | ¥ -969.33M | ¥ -1.04B | ¥ -1.05B | ¥ -955.23M | ¥ -756.86M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.53B | ¥ 1.20B | ¥ 1.67B | ¥ 2.55B | ¥ 96.37M |
| Total Assets | ¥ 4.56B | ¥ 4.28B | ¥ 4.46B | ¥ 4.62B | ¥ 1.59B |
| Total Debt | ¥ 2.60B | ¥ 2.07B | ¥ 1.26B | ¥ 752.83M | ¥ 333.98M |
| Net Debt | ¥ 1.07B | ¥ 878.39M | ¥ -386.81M | ¥ -1.74B | ¥ 237.61M |
| Total Liabilities | ¥ 4.02B | ¥ 2.72B | ¥ 1.88B | ¥ 1.11B | ¥ 574.15M |
| Stockholders' Equity | ¥ 349.51M | ¥ 1.57B | ¥ 2.58B | ¥ 3.52B | ¥ 1.01B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -447.93M | ¥ -1.29B | ¥ -1.28B | ¥ -1.26B | ¥ -624.47M |
| Operating Cash Flow | ¥ -290.22M | ¥ -956.44M | ¥ -782.73M | ¥ -719.17M | ¥ -410.56M |
| Investing Cash Flow | ¥ -199.31M | ¥ -291.55M | ¥ -509.62M | ¥ -602.80M | ¥ 7.77M |
| Financing Cash Flow | ¥ 791.92M | ¥ 831.70M | ¥ 444.94M | ¥ 3.72B | ¥ 195.65M |
Currency in CNY
